MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,604,225 | +27.2% | 1,243,585 | +30.2% | 0.00% | 0.0% |
| Q2 2023 | $1,260,694 | +71085.4% | 955,071 | -61.9% | 0.00% | 0.0% |
| Q1 2023 | $1,771 | +80.0% | 2,505,630 | +91.1% | 0.00% | 0.0% |
| Q4 2022 | $984 | -99.9% | 1,311,349 | +4.6% | 0.00% | 0.0% |
| Q3 2022 | $1,079,000 | +37.3% | 1,253,611 | +78.6% | 0.00% | – |
| Q2 2022 | $786,000 | -23.5% | 701,896 | -23.5% | 0.00% | -100.0% |
| Q1 2022 | $1,028,000 | -32.5% | 918,058 | -3.5% | 0.00% | 0.0% |
| Q4 2021 | $1,522,000 | -56.2% | 951,034 | -33.7% | 0.00% | -50.0% |
| Q3 2021 | $3,472,000 | -34.2% | 1,434,544 | -13.8% | 0.00% | -33.3% |
| Q2 2021 | $5,275,000 | -39.5% | 1,663,950 | -35.7% | 0.00% | -50.0% |
| Q1 2021 | $8,726,000 | +1412.3% | 2,589,367 | +1506.5% | 0.01% | – |
| Q4 2020 | $577,000 | – | 161,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
| Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
| DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
| Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
| Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
| Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
| Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
| Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |